Evidence map›Paper›PMID 39315121›Full record

ArticleJournal of market access & health policy2024

The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium.

Baudouin Standaert, Désirée Vandenberghe, Mark P Connolly, Johan Hellings

Abstract read
In one paragraph

Article in Journal of market access & health policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Baudouin StandaertDepartment of Care & Ethics, Faculty of Medicine & Life Sciences, University of Hasselt, 3590 Diepenbeek, Belgium; desiree.vandenberghe@uhasselt.be (D.V.); johan.hellings@uhasselt.be (J.H.).ORCID https://orcid.org/0000-0001-6801-9654
Désirée VandenbergheDepartment of Care & Ethics, Faculty of Medicine & Life Sciences, University of Hasselt, 3590 Diepenbeek, Belgium; desiree.vandenberghe@uhasselt.be (D.V.); johan.hellings@uhasselt.be (J.H.).ORCID https://orcid.org/0000-0002-6734-5367
Mark P ConnollyGlobal Market Access Solutions (GMAS), Charlotte, NC 28202, USA; mark@gmasoln.com.ORCID https://orcid.org/0000-0002-1886-745X
Johan HellingsDepartment of Care & Ethics, Faculty of Medicine & Life Sciences, University of Hasselt, 3590 Diepenbeek, Belgium; desiree.vandenberghe@uhasselt.be (D.V.); johan.hellings@uhasselt.be (J.H.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare is a huge business sector in many countries, focusing on the social function of delivering quality health when people develop illness. The system is essentially financed by public funds based on the solidarity principle. With a large financial outlay, the sector must use economic evaluation methods to achieve better efficiency. The objective of our study was to evaluate and to understand how health economics is used today, taking Belgium as an example of a high-income country. The evaluation started with a historical view of healthcare development and ended with potential projections for its future. A literature review focused on country-specific evaluation reports to identify the health economic methods used, with a search for potential gaps. The first results indicated that Belgium in 2021 devoted 11% of its GDP, 17% of its total tax revenue, and 30% of the national Social Security Fund to health-related activities, totalizing EUR 55.5 billion spending. The main health economic method used was a cost-effectiveness analysis linked to budget impact, assigning reimbursable monetary values to new products becoming available. However, these evaluation methods only impacted at most 20% of the money circulating in healthcare. The remaining 80% was subject to financial regulations (70%) and budgeting (10%), which could use many other techniques of an economic analysis. The evaluation indicated two potentially important changes in health economic use in Belgium. One was an increased focus on budgeting with plans, time frames, and quantified treatment objectives on specific disease problems. Economic models with simulations are very supportive in those settings. The other was the application of constrained optimization methods, which may become the new standard of practice when switching from fee-for-service to pay-per-performance as promoted by value-based healthcare and value-based health management. This economic refocusing to a more constrained approach may help to keep the healthcare system sustainable and affordable in the face of the many future challenges including ageing, climate change, migration, pandemics, logistical limitations, and financial instability.

Indexed as

budgetingeconomic assessmentfinancinghealthcarevalue assessment

Identifiers

PMID39315121
PMCPMC11417786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.